Will new agents impact survival in AML?

Rowe, Jacob M

Will new agents impact survival in AML? [electronic resource] - Best practice & research. Clinical haematology 12 2019 - 101094 p. digital

Publication Type: Journal Article; Review

1532-1924

10.1016/j.beha.2019.101094 doi


Aniline Compounds--therapeutic use
Disease-Free Survival
Drug Approval
Gemtuzumab--therapeutic use
Humans
Leukemia, Myeloid, Acute--drug therapy
Pyrazines--therapeutic use
Staurosporine--analogs & derivatives
Survival Rate
United States--epidemiology